期刊
CLINICAL AND TRANSLATIONAL ALLERGY
卷 4, 期 -, 页码 -出版社
BMC
DOI: 10.1186/2045-7022-4-41
关键词
Schnitzler's syndrome; Interleukin-1 beta; Autoinflammation; Chronic urticaria; Paraprotein; Monoclonal gammopathy
类别
资金
- Novartis
- SOBI
Schnitzler's syndrome is an autoinflammatory disorder characterized by the association of a monoclonal IgM (or IgG) gammopathy, a chronic urticarial rash, and signs and symptoms of systemic inflammation, including fever, arthralgias and bone pain. It was first described in 1972. This review summarizes the clinical features, efficacy of therapies, and follow-up data of the 281 cases that have been reported to date. Also, the results of skin histology, bone imaging, laboratory investigations, and studies of the pathogenesis will be discussed, including the pivotal role of interleukin-1 beta in this disorder.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据